Join our mailing list!
(Your shopping cart is empty)
Diane Publishing Books
Prescription Drugs: FDA Has Met Most Performance Goals for Reviewing Applications
Marcia G. Crosse (au)
The FDA is responsible for overseeing the safety and efficacy of drugs and biologics sold in the U.S. New drugs and biologics must be reviewed by FDA before they can be marketed. The FDA reviews new drug applications (NDA), biologic license applications (BLA), and efficacy supplements that propose changes to the way approved drugs and biologics are marketed or used. This report: (1) examines trends in FDAäó»s NDA and BLA review performance for FY 2000 through 2010; (2) examines trends in FDAäó»s efficacy supplement review performance for FYs 2000 through 2010; and (3) describes issues that have been raised about the drug and biologic review processes and steps FDA is taking that address them. A print on demand report.
Applique: The Ann Boyce Way
Secret World of the Spy: Stories of Espionage, Deception & Discovery
Not Fade Away: The On-Line World Remembers Jerry Garcia
Commonwealth of Science: ANZAAS & the Scientific Enterprise in Australia, 1888-1988
Share your knowledge of this product with other customers...
Be the first to write a review
Diane Publishing Co
PO Box 617
Darby, PA 19023-0617
Become an Affiliate
Send Us Feedback
Copyright ï¿½ 2004 Diane Publishing Company. All Rights Reserved.